JDL(SH:688057) Sou Hu Cai Jing·2025-12-22 10:05Core Viewpoint - Jindalai (688057) has announced an investment of 30 million yuan in Beijing Zhongke Hongtai Medical Technology Co., Ltd. to acquire a 10% stake, aiming to optimize its industrial structure and cultivate new profit growth points [1] Group 1: Stock Performance - As of December 22, 2025, Jindalai's stock closed at 12.4 yuan, up 3.77% from the previous trading day, with a total market capitalization of 3.422 billion yuan [1] - The stock opened at 13.0 yuan, reached a high of 13.5 yuan, and a low of 12.38 yuan, with a trading volume of 92.2442 million yuan and a turnover rate of 2.58% [1] Group 2: Investment Details - Jindalai plans to use its own funds of 30 million yuan for the investment, which is classified as a non-proportional capital increase and does not constitute a major asset restructuring or related party transaction [1] - The target company, Beijing Zhongke Hongtai, focuses on the research, production, and sales of medical robot technology and systems, and is incubated by the Chinese Academy of Sciences' Institute of Automation, possessing strong research capabilities and multiple independent intellectual property rights [1] - The products of the target company have entered the special review process for innovative medical devices by the National Medical Products Administration [1]